Apyx Medical Stock Story


USD 7.23  0.24  3.21%   

A current spike in volatility has left many investors looking confused. In this story, we will break down Apyx Medical Corp. We will analyze why it could be a much better year for Apyx Medical shareholders. Apyx Medical Corp is presently traded for 3.11. The entity has historical hype elasticity of -0.35. The average price elasticity to hype of competition is about -12.88. The firm is anticipated to decline in value after the next headline, with the price expected to drop to 2.76. The average volatility of media hype impact on the company stock price is huge, making predictions on the news or social media along less reliable. The price decrease on the next news is expected to be -11.25%, whereas the daily expected return is presently at -1.57 percent. The volatility of related hype on Apyx Medical is about 86.53% with expected price after next announcement by competition of -9.77 Given the investment horizon of 90 days the next anticipated press release will be in about 6 days.
Published over three months ago
View all stories for Apyx Medical | View All Stories

Will Apyx Medical (NASDAQ:APYX) price continue sliding?

This firm's average rating is Buy from 3 analysts.
We provide trade advice to complement the prevailing expert consensus on Apyx Medical Corp. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
The successful prediction of Apyx Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Apyx Medical Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Apyx Medical based on Apyx Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Apyx Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Apyx Medical's related companies.

Use Technical Analysis to project Apyx Medical expected Price

Apyx Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Apyx Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Apyx Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How does Apyx Medical utilize its cash?

To perform a cash flow analysis of Apyx Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Apyx Medical is receiving and how much cash it distributes out in a given period. The Apyx Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Apyx Medical Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Apyx Medical reported Net Cash Flow from Operations of (10.45 Million) in 2021

Exercise or conversion by Lawrence Waldman of 8000 shares of Apyx Medical subject to Rule 16b-3

Legal trades by Apyx Medical insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Apyx Medical insider trading alert for exercise of stock option (option to buy) by Lawrence Waldman, the corporate stakeholder, on 23rd of May 2022. This event was filed by Apyx Medical Corp with SEC on 2022-05-23. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.


The big decline in price over the last few months for Apyx Medical Corp could raise concerns from investors as the firm is trading at a share price of 3.11 on 172,200 in volume. The company management teams failed to add value to investors and position the firm supply of money to exploit market volatility in April. However, diversifying your holdings with Apyx Medical Corp or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.1. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Apyx Medical partners.

Deferred Revenue Breakdown

Apyx Medical Deferred Revenue yearly trend continues to be fairly stable with very little volatility. Deferred Revenue will likely drop to about 362.4 K in 2022. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Apyx Medical Deferred Revenue is fairly stable at the moment as compared to the past year. Apyx Medical reported Deferred Revenue of 364,500 in 2021

Will Apyx Medical instantly start a turnaround?

Current potential upside is at 6.9. Apyx Medical Corp is displaying above-average volatility over the selected time horizon. Investors should scrutinize Apyx Medical Corp independently to ensure intended market timing strategies are aligned with expectations about Apyx Medical volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Apyx Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Apyx Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Apyx Medical Implied Volatility

Apyx Medical's implied volatility exposes the market's sentiment of Apyx Medical Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Apyx Medical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Apyx Medical stock will not fluctuate a lot when Apyx Medical's options are near their expiration.

While some other companies in the medical devices industry are either recovering or due for a correction, Apyx Medical may not be performing as strong as the other in terms of long-term growth potentials. With a relatively neutral outlook on the current economy, it is better to hold off any trading of Apyx Medical as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Apyx Medical.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Apyx Medical Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com